VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 165 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $79 | -100.0% | 18,220 | -19.2% | 0.01% | -73.3% |
Q1 2022 | $255,000 | -53.1% | 22,541 | -35.0% | 0.03% | -50.0% |
Q4 2021 | $544,000 | +37.7% | 34,681 | +31.9% | 0.06% | +33.3% |
Q1 2021 | $395,000 | +237.6% | 26,293 | +132.9% | 0.04% | +95.7% |
Q1 2020 | $117,000 | -58.5% | 11,287 | -34.4% | 0.02% | -48.9% |
Q4 2019 | $282,000 | +59.3% | 17,193 | +29.1% | 0.04% | +45.2% |
Q3 2019 | $177,000 | -33.5% | 13,320 | -7.9% | 0.03% | -29.5% |
Q1 2019 | $266,000 | +9.9% | 14,457 | +0.9% | 0.04% | +22.2% |
Q1 2018 | $242,000 | -12.9% | 14,325 | -7.7% | 0.04% | -20.0% |
Q3 2017 | $278,000 | -17.0% | 15,521 | -24.3% | 0.04% | -28.6% |
Q2 2017 | $335,000 | +70.9% | 20,510 | +46.3% | 0.06% | +37.0% |
Q1 2017 | $196,000 | -22.8% | 14,023 | -8.2% | 0.05% | -32.4% |
Q3 2016 | $254,000 | -35.5% | 15,276 | -56.3% | 0.07% | -49.3% |
Q3 2015 | $394,000 | +162.7% | 34,928 | +196.0% | 0.13% | +157.7% |
Q2 2015 | $150,000 | – | 11,800 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |